Mirae Asset Global Investments’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-280,594
Closed -$152K – 1557
2020
Q2
$152K Buy
280,594
+17,718
+7% +$8.55K ﹤0.01% 1420
2020
Q1
$92K Sell
262,876
-36,326
-12% -$37.9K ﹤0.01% 1378
2019
Q4
$440K Sell
299,202
-18,882
-6% -$65.6K ﹤0.01% 1251
2019
Q3
$2.56M Sell
318,084
-4,900
-2% -$66.6K 0.02% 642
2019
Q2
$5.71M Sell
322,984
-5,774
-2% -$126K 0.04% 427
2019
Q1
$10.2M Sell
328,758
-6,281
-2% -$211K 0.07% 255
2018
Q4
$9.84M Sell
335,039
-64,742
-16% -$2.94M 0.09% 237
2018
Q3
$30.1M Buy
+399,781
New +$27.1M 0.22% 102

Other funds holding ASXC

Mirae Asset Global Investments's ASXC Position: Q3 2020 in Review

Mirae Asset Global Investments sold out of Asensus Surgical, Inc. (ASXC) in Q3 2020, closing a stake of 280,594 shares — an estimated $152K sold.

Mirae Asset Global Investments first reported a position in ASXC in Q3 2018 and held it in 8 quarters. The position peaked at $30.1M in Q3 2018. 67 funds tracked by Wall St. Rank hold ASXC as of Q3 2020.

  • Mirae Asset Global Investments reported no remaining Asensus Surgical, Inc. position as of Q3 2020 after selling out during the quarter.
  • Mirae Asset Global Investments sold 280,594 Asensus Surgical, Inc. shares in Q3 2020, an estimated $152K.
  • Mirae Asset Global Investments first reported a position in Asensus Surgical, Inc. in Q3 2018 and held it in 8 quarters.
  • Mirae Asset Global Investments's Asensus Surgical, Inc. position peaked at $30.1M in Q3 2018.
  • 67 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2020.

Based on Mirae Asset Global Investments's 13F filing for Q3 2020, filed 12 Nov 2020.